FDA Green Lights Astellas' Trial for Pompe Disease Therapeutic

Thursday, Astellas announced that the FDA had lifted its clinical hold for the company’s experimental gene therapy trial for late-onset Pompe disease.

Related Keywords

,Yuriko Nakao Getty ,Fortis ,X Linked Myotubular ,Resume ,Careers ,Da Green Lights Astellas 39 Trial For Pompe Disease Therapeutic ,Iospace ,Advice ,